Immuno-Biological Laboratories Co., Ltd. (4570.T)
JPY 474.0
(-0.84%)
JPY 474.0
(-0.84%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 321.91 Million JPY | 1.23% |
| 2022 | 318.01 Million JPY | -2.63% |
| 2021 | 326.58 Million JPY | 5.02% |
| 2020 | 310.96 Million JPY | -9.6% |
| 2019 | 344 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 323 Million JPY | 0.34% |
| 2023 Q2 | 324.91 Million JPY | 2.0% |
| 2023 Q1 | 318.53 Million JPY | 0.16% |
| 2023 Q3 | 331.7 Million JPY | 2.09% |
| 2023 Q4 | 321.91 Million JPY | -2.95% |
| 2023 FY | 321.91 Million JPY | 1.23% |
| 2022 Q3 | 348 Million JPY | 0.29% |
| 2022 FY | 318.01 Million JPY | -2.63% |
| 2022 Q4 | 318.01 Million JPY | -8.62% |
| 2022 Q2 | 346.98 Million JPY | 0.0% |
| 2021 FY | 326.58 Million JPY | 5.02% |
| 2020 FY | 310.96 Million JPY | -9.6% |
| 2019 FY | - JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 52.868% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -1695.488% |
| GNI Group Ltd. | 2.33 Billion JPY | 86.188% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 85.55% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -377.042% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 71.28% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -210.925% |
| AnGes, Inc. | 1.61 Billion JPY | 80.077% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -335.023% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 88.911% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -174852.717% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -129.708% |
| CanBas Co., Ltd. | 728 Thousand JPY | -44118.819% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -266.381% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -117.598% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -402.15% |
| Kidswell Bio Corporation | 875.65 Million JPY | 63.237% |
| PeptiDream Inc. | 2.4 Billion JPY | 86.61% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -5926.076% |
| Ribomic Inc. | 2.27 Million JPY | -14056.245% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -32191299900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -794.203% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -1010.045% |
| CellSource Co., Ltd. | 305.92 Million JPY | -5.226% |
| FunPep Company Limited | 25.54 Million JPY | -1160.377% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 11.576% |
| Stella Pharma Corporation | 1.11 Billion JPY | 71.161% |
| TMS Co., Ltd. | 50.02 Million JPY | -543.504% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -1440.18% |
| Cuorips Inc. | 1.04 Million JPY | -30764.142% |
| K Pharma,Inc. | 10.79 Million JPY | -2882.333% |
| Takara Bio Inc. | 11.85 Billion JPY | 97.283% |
| ReproCELL Incorporated | 248.14 Million JPY | -29.73% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 28.557% |
| StemCell Institute Inc. | 42.26 Million JPY | -661.708% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -40.841% |
| CellSeed Inc. | 46.19 Million JPY | -596.917% |